Evidence map›Paper›PMID 26016484›Full record

ArticleAddiction science & clinical practice2015

Trends in telemedicine use in addiction treatment.

Todd Molfenter, Mike Boyle, Don Holloway, Janet Zwick

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Child and adolescent psychiatry: challenges, solutions, opportunities, and future directions.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  11. Article
  12. Economic Impact of an Employer-Sponsored Integrated Digital Intervention Targeting Substance Use Disorders: Return on Investment Analysis.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Todd MolfenterCenter for Health Enhancement System Studies, University of Wisconsin-Madison, 4103 Mechanical Engineering Building, 1513 University Avenue, Madison, WI, 53706, USA. todd.molfenter@chess.wisc.edu.
Mike Boyle, 16030 Topsail Terrace, Lakewood Ranch, FL, 34202, USA.
Don Holloway, 6201 Chapel Hill Blvd., Plano, TX, 75093, USA. don@holloway.org.
Janet Zwick, 9219 Willard Ct., Urbandale, IA, 50322, USA. janetzwick@aol.com.

Funding

To Test A Payer/Treatment Agency Intervention to Increase Use of BuprenorphineR01DA030431 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI MOLFENTER, TODD DAVID · 2012 to 2016
$2.9M
NIDA NIH HHS R01 DA030431NIDA NIH HHS R01 DA030431-01A1
6 · The paper itself

Abstract

introductionTelemedicine use in addiction treatment and recovery services is limited. Yet, because it removes barriers of time and distance, telemedicine offers great potential for enhancing treatment and recovery for people with substance use disorders (SUDs). Telemedicine also offers clinicians ways to increase contact with SUD patients during and after treatment. CASE DESCRIPTION: A project conducted from February 2013 to June 2014 investigated the adoption of telemedicine services among purchasers of addiction treatment in five states and one county. The project assessed purchasers' interest in and perceived facilitators and barriers to implementing one or more of the following telemedicine modalities: telephone-based care, web-based screening, web-based treatment, videoconferencing, smartphone mobile applications (apps), and virtual worlds. DISCUSSION AND EVALUATION: Purchasers expressed the most interest in implementing videoconferencing and smartphone mobile devices. The anticipated facilitators for implementing a telemedicine app included funding available to pay for the telemedicine service, local examples of success, influential champions at the payer and treatment agencies, and meeting a pressing need. The greatest barriers identified were: costs associated with implementation, lack of reimbursement for telemedicine services, providers' unfamiliarity with technology, lack of implementation models, and confidentiality regulations. This paper discusses why the project participants selected or rejected different telemedicine modalities and the policy implications that purchasers and regulators of addiction treatment services should consider for expanding their use of telemedicine.

conclusionsThis analysis provides initial observations into how telemedicine is being implemented in addiction services in five states and one county. The project demonstrated that despite the considerable interest in telemedicine, implementation challenges exist. Future studies should broaden the sample analyzed and track technology implementation longitudinally to help the research and practitioner communities develop a greater understanding of technology implementation trends and practices.

Indexed as

HumansInternetMobile ApplicationsSubstance-Related DisordersTelemedicineTelephoneUser-Computer InterfaceVideoconferencing

Identifiers

PMID26016484
PMCPMC4636787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.